LAWSON BYRON (SVP/Chief Commercial Officer) reported 1 transaction at HTG MOLECULAR DIAGNOSTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 7/1/2022ACC: 0001209191-22-040341
Officer· SVP/Chief Commercial Officer
Since Jan 2020
-23.00
Net shares
Net seller
$23.69
Total sold
0
Open market trades
0B · 0S
1
Total transactions
23.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−23.00
Price / share
$1.03
Trade value
$23.69
% of position
0.5%
6/30/2022
5.06K→5.03K
Total
Net shares
−23.00
Net value
-$23.69
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2022 | F · Tax Withholding | −23.00 | $1.03 | $23.69 | 0.5% | 5.06K | 5.03K |
| Total | −23.00 | -$23.69 | ||||||
Derivative Transactions0
No derivative transactions reported